Medcom has won the ‘Polish Industry Changer’ award from Magazyn Gospodarczy Nowy Przemysł and the wnp.pl website.
The award ceremony was held on 27 February during the gala concluding the Changing Polish Industry Forum.
Medcom was recognised for successful expansion in the global market and an innovative approach to the design and manufacture of power electronic devices for electric vehicles, industrial installations and power systems. The title was officially accepted by Marek Niewiadomski, president of Medcom, and awarded by Małgorzata Oleszczuk, president of the Polish Agency for Enterprise Development.
Most railway vehicles manufactured or modernised in Poland within the last decade are equipped with Medcom devices. We deliver our products to more than 30 countries and export generates about 30% of the company’s turnover. The largest foreign markets include Brazil, Turkey, China and the United States.
Our solutions are used on a daily basis by major manufacturers of vehicles and devices for public transport such as CAF, Hyundai Rotem, Mitsubishi Electric and Siemens USA, as well as manufacturers of rolling stock operating in the local and regional markets, Newag, Solaris, Pesa, and Modertrans.
The editorial team also recognised our company for consistently developing and improving a range of devices manufactured using state-of-the-art silicon carbide (SiC) technology. Medcom is currently one of the few companies in the world specialising in solutions based on SiC technology, which makes it possible to produce lighter and smaller power electronic devices providing higher energy efficiency.
The Changing Polish Industry Forum is one of the more important forums for debate on the changes occurring in the Polish economy and the prospects for its development. One of the participants in the debate was the vice-president of Medcom, Piotr Wroński.
During the discussion panel titled ‘Polish companies in foreign markets’, he talked, among other things, about the leading and most promising directions of expansion for Polish companies, building a competitive advantage in foreign markets, and effective mitigation of the risks related to a presence in foreign markets.